Committees

Andreï Turtoi
Head of Tumor Microenvironment and Resistance to Treatment Lab
Institut de Recherche en Cancérologie de Montpellier

Alain Beck
Senior Director, NBEs Analytical Chemistry
Centre d’Immunologie Pierre Fabre

André Pèlegrin
Deputy Director LabEx MAbImprove, Group Leader
Institut de Recherche en Cancérologie de Montpellier

Thierry Wurch
Director – Immuno-Oncology External Research & Innovation
Institut de Recherches SERVIER

Pierre Martineau
Group Leader & IRCM Deputy Director
Institut de Recherche en Cancérologie de Montpellier

Roland Beliard
CEO
LFB Biomanufacturing
Business Development Manager
LFB Biotechnologies

Sylvain Huille
Head of Formulation, Biotherapeutics
Sanofi

Nicolas Poirier
Chief Scientific Officer
OSE Immunotherapeutics

Ana Antunes
Science and Communication Officer
MabDesign

Jérôme Tiollier
EVP Chief Development Officer
INNATE PHARMA

François Romagné
Scientific Director
MI-mAbs

André Pèlegrin
Deputy Director LabEx MAbImprove, Group Leader
Institut de Recherche en Cancérologie de Montpellier

Pierre Martineau
Group Leader & IRCM Deputy Director
Institut de Recherche en Cancérologie de Montpellier

Nicolas Groux
Chief Operating Officer
MabDesign